NCT05709756

Brief Summary

Patients with documented atrial fibrillation who were referred to our clinic for catheter ablation will undergo standard HPSD ablation and subsequent esophagoscopy. After esophagoscopy patients will be followed up for one month in the form of a telephone follow-up. The primary endpoint of the study assessed by esophagoscopy performed on the day after the index catheter ablaton is the incidence of esophageal thermal lesions. Secondary endpoints include:

  1. 1.The size of the esophageal thermal lesions.
  2. 2.The severity of esophageal thermal lesions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
263

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 2, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

October 2, 2023

Status Verified

January 1, 2023

Enrollment Period

2.4 years

First QC Date

January 24, 2023

Last Update Submit

September 29, 2023

Conditions

Keywords

Atrial FibrillationEsophagus InjuryPulmonary vein isolationEsophagoscopy

Outcome Measures

Primary Outcomes (1)

  • Prevalence of ablation-related esophageal thermal lesions

    It will be assessed by means of Esophagoscopy

    One day after Catheter ablation

Secondary Outcomes (2)

  • Size of ablation-related esophageal thermal lesions

    One day after Catheter ablation

  • Severity of ablation-related esophageal thermal lesions

    One day after Catheter ablation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with documented atrial fibrillation who were referred to our clinic for pulomary vein isolation

You may qualify if:

  • Atrial fibrillation documented in the 12-lead ECG
  • Indication for catheter ablation in accordance with currentn ESC guidelines

You may not qualify if:

  • Pregnancy
  • Women of childbearing potential without a negative pregnancy test within 48 hours prior to ablation procedure
  • Known intracardiac or other thrombi
  • Contraindication to anticoagulation
  • Contraindication to esophagoscopy: diseases and deformities of the cervical spine, esophageal varices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Arash Arya

Leipzig, Saxony, 04289, Germany

Location

Department of Electrophysiology, Leipzig Heart Center at University of Leipzig

Leipzig, Saxony, 04289, Germany

Location

Related Publications (1)

  • Wolff C, Langenhan K, Wolff M, Efimova E, Zachaus M, Darma A, Dinov B, Seewoster T, Nedios S, Bertagnolli L, Wolff J, Paetsch I, Jahnke C, Bollmann A, Hindricks G, Bode K, Halm U, Arya A. Incidence and predictors of thermal oesophageal and vagus nerve injuries in Ablation Index-guided high-power-short-duration ablation of atrial fibrillation: a prospective study. Europace. 2024 May 2;26(5):euae107. doi: 10.1093/europace/euae107.

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gerhard Hindricks, MD

    Leipzig Heart Center at University of Leipzig

    STUDY CHAIR
  • Arash Arya, MD

    Leipzig Heart Center at University of Leipzig

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2023

First Posted

February 2, 2023

Study Start

March 1, 2021

Primary Completion

August 1, 2023

Study Completion

September 1, 2023

Last Updated

October 2, 2023

Record last verified: 2023-01

Locations